Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2015 08:00 ET | Source: Nanosphere, Inc.

Nanosphere to Announce Third Quarter Financial Results & Host Investor Call on Monday, November 9

NORTHBROOK, Ill., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced today that it will report...
September 22, 2015 08:00 ET | Source: Nanosphere, Inc.

Impact of Verigene Blood Culture Tests Highlighted by Five Studies Presented at ICAAC 2015

NORTHBROOK, Ill., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced that new clinical data...
September 08, 2015 08:00 ET | Source: Nanosphere, Inc.

Nanosphere Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test

NORTHBROOK, Ill., Sept. 8, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing the practice of medicine through targeted molecular diagnostics, today announced it has received...
August 10, 2015 16:01 ET | Source: Nanosphere, Inc.

Nanosphere Announces Record Q2 2015 Results

NORTHBROOK, Ill., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results...
July 31, 2015 08:00 ET | Source: Nanosphere, Inc.

Nanosphere Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders

NORTHBROOK, Ill., July 31, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that it has amended certain...
June 22, 2015 16:01 ET | Source: Nanosphere, Inc.

New Studies Highlight Antibiotic Resistance Detection With Nanosphere's Verigene Blood Culture Tests

NORTHBROOK, Ill., June 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that seven studies evaluating...
June 08, 2015 16:14 ET | Source: Nanosphere, Inc.

Nanosphere Announces $4.4 Million at the Market Registered Direct Offering

NORTHBROOK, Ill., June 8, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced today that it has entered into a...
May 27, 2015 16:01 ET | Source: Nanosphere, Inc.

Eighteen New Verigene Clinical and Economic Studies Presented at CVS, ECCMID and MAD-ID 2015

NORTHBROOK, Ill., May 27, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that 18 studies performed by...
May 15, 2015 09:00 ET | Source: Nanosphere, Inc.

Nanosphere Announces Closing of New and Expanded Debt Facility and $4.4 Million at the Market Registered Direct Offering

NORTHBROOK, Ill., May 15, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today the closing of its previously...
May 11, 2015 17:30 ET | Source: Nanosphere, Inc.

Nanosphere Announces Record Q1 2015 Results, New and Expanded Debt Facility, $4.4 Million at the Market Registered Direct Offering and Next Generation Verigene System Progress

Corporate Highlights: Record Q1 revenues of $4.6 million confirming full year guidance New and Expanded Debt Facility Pricing of $4.4 million at the market registered...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right